Back to Screener

Healthcare

PT Kalbe Farma Tbk.(PTKFY)

Live Price

Offline

$8.58

+0.00% today

1Y Change

-50.44%

Window

Jun 23, 2025 โ†’ Jun 11, 2026

Market Cap
$39.17T
Revenue Growth
+8.3%
EPS Growth
+15.3%
Dividend Yield
4.2%

Coverage: 244 bars ยท Jun 23, 2025 โ†’ Jun 11, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

PT Kalbe Farma Tbk. (PTKFY) is a Healthcare stock with a market cap of $39.17T and listed on OTC. The stock last traded around $8.58 and down 50.4% across the available one-year price window (Jun 23, 2025 โ†’ Jun 11, 2026). Baseline metrics include revenue growth of +8.3%, EPS growth of +15.3%, a dividend yield of 4.2%. What stands out right now is revenue +8.3%, EPS +15.3%, free cash flow -30.4% with operating margin 12.3% and ROIC 13.2%. The dividend matters to the case here, with a current yield around 4.2%. Valuation is more restrained than many high-expectation growth names at P/E 10.8 and price/sales 1.1. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines PTKFY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

PTKFY

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

PTKFY Max Drawdown

-56.02%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for PTKFY and SPY.

Calendar-year return history is still loading or unavailable.

EPS Consensus

0.00

Range 0.00 โ†’ 0.00

No analyst count

Revenue Outlook

$134530.12T

Range $131711.52T โ†’ $137348.72T

No analyst count

vs prior: -5.6%

Consensus Spread

EPS spreadโ€”
Revenue spread4.2%

Lower spread suggests tighter agreement across covering analysts.

Trend

EPS trend

Consensus average across visible periods

0.00
Latest visible period
Q1 2025Q3 2025
3 visible points

Trend

Revenue trend

Average analyst revenue estimate

$134530.12T
Latest visible period
Q1 2025Q3 2025
3 visible pointstrend: -5.6%

Timeline

Analyst forecast ladder

Sorted by period end date. Includes both cached rows and live fallbacks from FMP.

Q3 2025
Ends Sep 30, 2025
quarter
Revenue
$134530.12T
$131711.52T to $137348.72T
EPS
0.00
0.00 to 0.00
No analyst count
EPS: No analyst count
Apr 30, 05:25 PM UTC
stable/analyst-estimates
Q2 2025
Ends Jun 30, 2025
quarter
Revenue
$142515.63T
$142515.63T to $142515.63T
EPS
0.00
0.00 to 0.00
No analyst count
EPS: No analyst count
Apr 30, 05:25 PM UTC
stable/analyst-estimates
Q1 2025
Ends Mar 31, 2025
quarter
Revenue
$147110.28T
$147110.28T to $147110.28T
EPS
0.00
0.00 to 0.00
No analyst count
EPS: No analyst count
Apr 30, 05:25 PM UTC
stable/analyst-estimates

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.